Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

The following is a summary of "Clinical Characteristics and Outcomes Stratified by Time to ST-Segment Elevation Myocardial Infarction Presentation," published in the March 2025 issue of American ...

Patients with gout living in rural vs urban areas face a significantly higher risk for MI-related hospitalization.

Adding ezetimibe (Zetia) therapy to statins early after a heart attack improved outcomes, Swedish national records suggested.

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...

Giving patients a combination of drugs earlier in their treatment could prevent thousands of heart attacks, according to a new study. Patients should be treated earlier with statins and the ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event.

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

Patients who get an add-on medication soon after a heart attack have a better prognosis than those who receive it later, or ...

The Philippine Health Insurance Corporation (PhilHealth) has paid the Philippine General Hospital (PGH) PHP22.8 million for ...